Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2013

01.12.2013 | Short Research Report

Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia

verfasst von: Jian Lynn Lee, Adyani Md Redzuan, Noraida Mohamed Shah

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Background Unlicensed and off-label use of medicines in paediatrics is widespread. However, the incidence of this practice in Malaysia has not been reported. Objective To determine the extent of unlicensed and off-label use of medicines in hospitalised children in the intensive care units of a tertiary care teaching hospital. Methods A prospective, observational exploratory study was conducted on medicines prescribed to children admitted to the 3 intensive care units of Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Results A total of 194 patients were admitted to UKMMC, 168 of them received one or more drugs. Of 1,295 prescriptions, 353 (27.3 %) were unlicensed and 442 (34.1 %) were for off-label use. Forty-four percent of patients received at least one medicine for unlicensed use and 82.1 % received at least one medicine off-label. Preterm infants, children aged 28 days to 23 months, patients with hospital stays of more than 2 weeks, and those prescribed increasing numbers of medicines were more likely to receive medicines for unlicensed use. Term neonates and patients prescribed increasing numbers of medicines had increased risk of receiving medicines for off-label use. Conclusion Prescribing of medicines in an unlicensed or off-label fashion to the children in the intensive care units of UKMMC was common. Further detailed studies are necessary to ensure the delivery of safe and effective medicines to children.
Literatur
1.
Zurück zum Zitat Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343–5.PubMedCrossRef Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343–5.PubMedCrossRef
2.
Zurück zum Zitat Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. N Engl J Med. 1960;262:787–94.PubMedCrossRef Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. N Engl J Med. 1960;262:787–94.PubMedCrossRef
3.
Zurück zum Zitat Silverman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics. 1956;18(4):614–25.PubMed Silverman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics. 1956;18(4):614–25.PubMed
4.
Zurück zum Zitat Gazarian M. Why are children still therapeutic orphans? Aust Prescr. 2003;26(6):122–3. Gazarian M. Why are children still therapeutic orphans? Aust Prescr. 2003;26(6):122–3.
5.
Zurück zum Zitat Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282–90.PubMedCrossRef Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282–90.PubMedCrossRef
6.
Zurück zum Zitat Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:F142–5.PubMedCrossRef Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:F142–5.PubMedCrossRef
7.
Zurück zum Zitat ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJM, Tibboel D, van den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch Children’s Hospital. Pediatrics. 2001;108(5):1089–93.PubMedCrossRef ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJM, Tibboel D, van den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch Children’s Hospital. Pediatrics. 2001;108(5):1089–93.PubMedCrossRef
8.
Zurück zum Zitat Bajcetic M, Jelisavcic M, Mitrovic J, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61:775–9.PubMedCrossRef Bajcetic M, Jelisavcic M, Mitrovic J, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61:775–9.PubMedCrossRef
9.
Zurück zum Zitat Dessi A, Salemi C, Fanos V, Cuzzolin L. Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci. 2010;32:120–4.PubMedCrossRef Dessi A, Salemi C, Fanos V, Cuzzolin L. Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci. 2010;32:120–4.PubMedCrossRef
10.
Zurück zum Zitat Lass J, Kaar R, Jogi K, Varendi H, Metsvaht T, Lutsar I. Drug utilization pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011;67(12):1263–71.PubMedCrossRef Lass J, Kaar R, Jogi K, Varendi H, Metsvaht T, Lutsar I. Drug utilization pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011;67(12):1263–71.PubMedCrossRef
11.
Zurück zum Zitat Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain SS, Jadhav S. Off-label drug use in a pediatric intensive care unit. Indian J Pediatr. 2009;76:1113–8.PubMedCrossRef Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain SS, Jadhav S. Off-label drug use in a pediatric intensive care unit. Indian J Pediatr. 2009;76:1113–8.PubMedCrossRef
12.
Zurück zum Zitat O’Donnelle CPF, Stone RJ, Morley C. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics. 2002;110(5):e52.CrossRef O’Donnelle CPF, Stone RJ, Morley C. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics. 2002;110(5):e52.CrossRef
13.
Zurück zum Zitat Khdour MR, Hallak HO, Alayasa KSA, AlShahed QN, Hawwa AF, McElnay JC. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm. 2011;33(4):650–5.PubMedCrossRef Khdour MR, Hallak HO, Alayasa KSA, AlShahed QN, Hawwa AF, McElnay JC. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm. 2011;33(4):650–5.PubMedCrossRef
16.
Zurück zum Zitat Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, Alex R, Hempenstall J. Preparation of medicines for children—a hierarchy of classification. Int J Pharm. 2012;435(2):124–30.PubMedCrossRef Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, Alex R, Hempenstall J. Preparation of medicines for children—a hierarchy of classification. Int J Pharm. 2012;435(2):124–30.PubMedCrossRef
Metadaten
Titel
Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia
verfasst von
Jian Lynn Lee
Adyani Md Redzuan
Noraida Mohamed Shah
Publikationsdatum
01.12.2013
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2013
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9846-0

Weitere Artikel der Ausgabe 6/2013

International Journal of Clinical Pharmacy 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.